These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 8682657

  • 1. Effects of hypolipidemic drugs on the expression of genes involved in high density lipoprotein metabolism in the rat.
    Staels B, Van Tol A, Fruchart JC, Auwerx J.
    Isr J Med Sci; 1996 Jun; 32(6):490-8. PubMed ID: 8682657
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The effect of the HMG-CoA reductase inhibitor simvastatin and of cholestyramine on hepatic apolipoprotein mRNA levels in the rat.
    Mitchell A, Fidge N, Griffiths P.
    Biochim Biophys Acta; 1993 Mar 17; 1167(1):9-14. PubMed ID: 8461338
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Different VLDL apo B, and HDL apo AI and apo AII metabolism in two heterozygous carriers of unrelated mutations in the lipoprotein lipase gene.
    Pérez-Méndez O, Duhal N, Lacroix B, Bonte JP, Fruchart JC, Luc G.
    Clin Chim Acta; 2006 Jun 17; 368(1-2):149-54. PubMed ID: 16487502
    [Abstract] [Full Text] [Related]

  • 7. Regulation of hepatic cholesterol metabolism in CETP/LDLr mice by cholesterol feeding and by drugs (cholestyramine and lovastatin) that lower plasma cholesterol.
    Harada LM, Carrilho AJ, Oliveira HC, Nakandakare ER, Quintão EC.
    Clin Exp Pharmacol Physiol; 2006 Dec 17; 33(12):1209-15. PubMed ID: 17184503
    [Abstract] [Full Text] [Related]

  • 8. Apolipoprotein modifying effects of statins and fibrate in various age groups of coronary artery disease patients.
    Sharma R, Mahajan M, Singh B, Bal BS, Kant R.
    J Indian Med Assoc; 2006 Sep 17; 104(9):492-4, 496, 498. PubMed ID: 17388006
    [Abstract] [Full Text] [Related]

  • 9. Induction of bile acid synthesis by cholesterol and cholestyramine feeding is unimpaired in mice deficient in apolipoprotein AI.
    Jolley CD, Dietschy JM, Turley SD.
    Hepatology; 2000 Dec 17; 32(6):1309-16. PubMed ID: 11093738
    [Abstract] [Full Text] [Related]

  • 10. [The effect of expressed human apolipoprotein AI on plasma high density lipoprotein level in transgenic mice].
    Li H, Gu S, She M.
    Zhonghua Yi Xue Za Zhi; 1998 Jul 17; 78(7):531-3. PubMed ID: 10923465
    [Abstract] [Full Text] [Related]

  • 11. [Intestinal apolipoprotein metabolism].
    Steinmetz A.
    Klin Wochenschr; 1990 Jul 17; 68 Suppl 22():12-8. PubMed ID: 2087069
    [Abstract] [Full Text] [Related]

  • 12. Apolipoprotein AI and apolipoprotein E mRNA expression in peripheral white blood cells from patients with orthotopic liver transplantation.
    Martínez-López E, Nuño-González P, Ruiz-Madrigal B, Rodríguez-Sancho LC, Hernández-Nazará ZH, Segura-Ortega JE, Panduro A.
    Liver Int; 2007 Sep 17; 27(7):930-7. PubMed ID: 17696931
    [Abstract] [Full Text] [Related]

  • 13. Hepatic cholesterol and bile acid synthesis, low-density lipoprotein receptor function, and plasma and fecal sterol levels in mice: effects of apolipoprotein E deficiency and probucol or phytosterol treatment.
    Moghadasian MH, Nguyen LB, Shefer S, Salen G, Batta AK, Frohlich JJ.
    Metabolism; 2001 Jun 17; 50(6):708-14. PubMed ID: 11398149
    [Abstract] [Full Text] [Related]

  • 14. Mechanism of action of niacin.
    Kamanna VS, Kashyap ML.
    Am J Cardiol; 2008 Apr 17; 101(8A):20B-26B. PubMed ID: 18375237
    [Abstract] [Full Text] [Related]

  • 15. Fibrates influence the expression of genes involved in lipoprotein metabolism in a tissue-selective manner in the rat.
    Staels B, van Tol A, Andreu T, Auwerx J.
    Arterioscler Thromb; 1992 Mar 17; 12(3):286-94. PubMed ID: 1547188
    [Abstract] [Full Text] [Related]

  • 16. Fibrate treatment does not modify the expression of acyl coenzyme A oxidase in human liver.
    Roglans N, Bellido A, Rodríguez C, Cabrero A, Novell F, Ros E, Zambón D, Laguna JC.
    Clin Pharmacol Ther; 2002 Dec 17; 72(6):692-701. PubMed ID: 12496750
    [Abstract] [Full Text] [Related]

  • 17. G to A substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipoprotein AI and high density lipoprotein cholesterol concentrations.
    Jeenah M, Kessling A, Miller N, Humphries S.
    Mol Biol Med; 1990 Jun 17; 7(3):233-41. PubMed ID: 1977072
    [Abstract] [Full Text] [Related]

  • 18. Clinical investigation on the hypolipidemic effect of simvastatin versus probucol in hemodialysis patients.
    Fiorini F, Patrone E, Castelluccio A.
    Clin Ter; 1994 Sep 17; 145(9):213-7. PubMed ID: 7813167
    [Abstract] [Full Text] [Related]

  • 19. Apolipoprotein E*3-Leiden transgenic mice as a test model for hypolipidaemic drugs.
    van Vlijmen BJ, Pearce NJ, Bergö M, Staels B, Yates JW, Gribble AD, Bond BC, Hofker MH, Havekes LM, Groot PH.
    Arzneimittelforschung; 1998 Apr 17; 48(4):396-402. PubMed ID: 9608883
    [Abstract] [Full Text] [Related]

  • 20. The human apolipoprotein genes.
    Scott J.
    Oxf Surv Eukaryot Genes; 1987 Apr 17; 4():168-97. PubMed ID: 2908023
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.